[23] In the diseased brain, GLP-1 receptor agonist treatment is associated with protection against a range of experimental disease models such as Parkinson's disease, [24] [18] Alzheimer's disease, [25] [26] stroke, [24] traumatic brain injury, [14] [19] and multiple sclerosis
At the same time, aging also means declining glutathione synthesis, which offsets the negative impact of reactive oxygen species on the bodys cell health and functions
Ngi trn 18 tui c th s dng vin ung trng da glutathione 600 c ci thin tt nht cn s dng liu trnh ung glutathione 600 mi mang li kt qu cao nht, liu trnh ung l 6 hp trong 3 thng s dng
doi:10.1016/j.freeradbiomed.2010.09.006 2
Instead, it influences melanin production and can lead to a more even skin tone over time
Role of short-chain fatty acids in host physiology